NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/19/2019
Back to search
Official data from USPTO
CELLDEX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
07/19/2019
Trademark type
Combined
Nice classes
5
Filing date
10/18/2004
Registration date
06/16/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/19/2019
Last transaction
07/19/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/12/2009
First use in commerce
04/13/2009
Drawing code
3
Owner type
03
Owner location
Hampton, NJ
Examiner
FRENCH, CURTIS
Law office
M60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the words "CELLDEX THERAPEUTICS" with an abstract depiction of an antibody.
Holders and representatives
Holders
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.
Representatives
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccinestherapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancerautoimmune disordersinfectious diseases and graft-verus-host disease
Publications
History of USPTO decisions and trademark events.
52 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/19/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/19/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/19/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
06/12/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/16/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/06/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/06/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/23/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/23/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2015
E815
TEAS SECTION 8 & 15 RECEIVED
04/13/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/19/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/19/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/08/2009
ALIE
ASSIGNED TO LIE
05/08/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/08/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/06/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/06/2009
PAPER RECEIVED
04/20/2009
IUAF
USE AMENDMENT FILED
04/17/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/15/2008
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/15/2008
EX5G
SOU EXTENSION 5 GRANTED
10/14/2008
EXT5
SOU EXTENSION 5 FILED
10/14/2008
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2008
EX4G
SOU EXTENSION 4 GRANTED
04/18/2008
EXT4
SOU EXTENSION 4 FILED
04/18/2008
EEXT
SOU TEAS EXTENSION RECEIVED
04/18/2008
EX3G
SOU EXTENSION 3 GRANTED
10/18/2007
EXT3
SOU EXTENSION 3 FILED
10/18/2007
EEXT
SOU TEAS EXTENSION RECEIVED
10/18/2007
EX2G
SOU EXTENSION 2 GRANTED
04/17/2007
EXT2
SOU EXTENSION 2 FILED
04/17/2007
EEXT
SOU TEAS EXTENSION RECEIVED
04/17/2007
EX1G
SOU EXTENSION 1 GRANTED
10/18/2006
EXT1
SOU EXTENSION 1 FILED
10/18/2006
EEXT
SOU TEAS EXTENSION RECEIVED
10/18/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
04/18/2006
PUBO
PUBLISHED FOR OPPOSITION
01/24/2006
NPUB
NOTICE OF PUBLICATION
01/04/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/08/2005
ALIE
ASSIGNED TO LIE
12/02/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/26/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/25/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/20/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2005
GNRT
NON-FINAL ACTION E-MAILED
05/20/2005
CNRT
NON-FINAL ACTION WRITTEN
05/20/2005
DOCK
ASSIGNED TO EXAMINER
05/19/2005
NWAP
NEW APPLICATION ENTERED
10/26/2004
Continuous trademark protection
Get notified about every new filing that threatens CELLDEX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.